Colonial Trust Advisors’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-15,750
Closed -$133K – 139
2015
Q4
$133K Hold
15,750
– – 0.04% 135
2015
Q3
$66K Hold
15,750
– – 0.02% 132
2015
Q2
$83K Buy
15,750
+1,000
+7% +$6.41K 0.03% 132
2015
Q1
$91K Buy
+14,750
New +$94.5K 0.03% 134

Colonial Trust Advisors's OCAT Position: Q1 2016 in Review

Colonial Trust Advisors sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 15,750 shares — an estimated $133K sold.

Colonial Trust Advisors first reported a position in OCAT in Q1 2015 and held it in 4 quarters. The position peaked at $133K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Colonial Trust Advisors reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Colonial Trust Advisors sold 15,750 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $133K.
  • Colonial Trust Advisors first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q1 2015 and held it in 4 quarters.
  • Colonial Trust Advisors's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $133K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Colonial Trust Advisors's 13F filing for Q1 2016, filed 13 May 2016.